Cargando…

Novel targeted therapies and immunotherapy for advanced thyroid cancers

Thyroid cancer is a frequently encountered endocrine malignancy. Despite the favorable prognosis of this disease, 15–20% of differentiated thyroid cancer (DTC) cases and most anaplastic types, remain resistant to standard treatment options, including radioactive iodine (RAI). In addition, around 30%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naoum, George E., Morkos, Michael, Kim, Brian, Arafat, Waleed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817719/ https://www.ncbi.nlm.nih.gov/pubmed/29455653 http://dx.doi.org/10.1186/s12943-018-0786-0

Ejemplares similares

Role of nanotechnology and gene delivery systems in TRAIL-based therapies
por: Naoum, George E, et al.
Publicado: (2016)

Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology
por: Naoum, George E., et al.
Publicado: (2017)

Advances in targeted therapy and immunotherapy for esophageal cancer
por: Yang, Haiou, et al.
Publicado: (2023)

Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021)

Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs
por: Naoum, George E., et al.
Publicado: (2017)

Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
por: Mishra, Prachi, et al.
Publicado: (2021)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)

Advances in targeted therapy and immunotherapy for melanoma (Review)
por: Qin, Ziyao, et al.
Publicado: (2023)

Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022)

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy
por: Niezgoda, Anna, et al.
Publicado: (2015)

SAT480 Diagnosing Dysphagia Due to Thyroid Nodules by Thyroid Ultrasound and the Effectiveness of Radiofrequency Ablation
por: Idrees, Zarwa, et al.
Publicado: (2023)

Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
por: Laface, Carmelo, et al.
Publicado: (2023)

Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
por: Yuan, Jiaqian, et al.
Publicado: (2022)

Personalization of Targeted Therapy in Advanced Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2014)

Editorial: Targeted therapy in advanced thyroid cancer
por: Boucai, Laura
Publicado: (2022)

Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza
por: Queiroz, Marcello Moro, et al.
Publicado: (2023)

Targeted and novel therapy in advanced gastric cancer
por: Selim, Julie H., et al.
Publicado: (2019)

Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients
por: Arafat, Waleed, et al.
Publicado: (2016)

Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
por: Badrinath, Narayanasamy, et al.
Publicado: (2019)

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
por: Russo, Irene, et al.
Publicado: (2018)

Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review
por: Al-Jundi, Mohammad, et al.
Publicado: (2020)

Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011)

The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer
por: Leong, Alessandra, et al.
Publicado: (2020)

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2022)

Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
por: Shi, Jinhong, et al.
Publicado: (2020)

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
por: Bouyahya, Abdelhakim, et al.
Publicado: (2022)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
por: Barsouk, Adam, et al.
Publicado: (2019)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
por: Sun, Xiaolu, et al.
Publicado: (2022)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021)

Advancements in Cancer Immunotherapies
por: Roy, Ruchi, et al.
Publicado: (2022)

Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma
por: Du, Jiajia, et al.
Publicado: (2023)

Neutron radiation therapy for advanced thyroid cancers
por: Chapman, Tobias R., et al.
Publicado: (2016)

New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
por: Wong, Kai-Pun, et al.
Publicado: (2012)

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
por: Cheng, Yuan, et al.
Publicado: (2021)

Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy
por: Gómez-Navarro, Jesús, et al.
Publicado: (2000)

Cancer neoantigens as potential targets for immunotherapy
por: Ma, Weijie, et al.
Publicado: (2021)

Novel targets for immunotherapy in glomerulonephritis
por: Foster, Mary H
Publicado: (2008)

SAT468 Assessment of Peak Systolic Velocity of Various Thyroid Arteries
por: Raju, Karishma, et al.
Publicado: (2023)

Advances of Electroporation-Related Therapies and the Synergy with Immunotherapy in Cancer Treatment
por: Gong, Xuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lt0i55rl6lpgjgsuhfe7vlef6u